[LGND] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -163.07%
YoY- -506.02%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 72,473 69,990 27,003 59,590 50,464 38,185 21,192 22.72%
PBT -7,026 3,370 -8,175 -56,789 30,665 7,230 5,826 -
Tax -2,058 -2,391 -810 -14,307 37,675 10,355 -515 25.94%
NP -4,968 5,761 -7,365 -42,482 -7,010 -3,125 6,341 -
Tax Rate - 70.95% - - -122.86% -143.22% 8.84% -
Total Cost 77,441 64,229 34,368 102,072 57,474 41,310 14,851 31.65%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -6.85 8.23 -27.27 -71.29 -13.89 -8.18 29.92 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.30 0.36 -0.43 -2.02 -0.34 -0.15 0.32 -
EPS Diluted -0.30 0.35 -0.43 -2.02 -0.33 -0.15 0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.